A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?

NCT ID NCT07761416

Not yet recruiting Prevention Sponsor: St. Joseph's Healthcare Hamilton Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study tests whether it is practical and safe to remove the fallopian tubes during planned weight-loss (bariatric) surgery as a way to lower the risk of ovarian cancer. Many ovarian cancers are thought to start in the fallopian tubes, and removing them can reduce risk by about 80%. The trial will enroll people who are already having bariatric surgery and have completed child-bearing, tracking how often the additional procedure is successful and whether it adds complications or hospital time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Opportunistic salpingectomy (removal of fallopian tubes) during bariatric surgery
What this could lead to: If successful, this could make ovarian cancer prevention more accessible by offering fallopian tube removal during weight-loss surgery.
What could go wrong: This is an early feasibility study, so it may not prove the procedure reduces cancer risk. It also causes sterilization, which may not be acceptable to all.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ovarian cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BARIATRIC SURGERY OPPORTUNISTIC SALPINGECTOMY OVARIAN CANCER

More trials for these conditions

Other studies related to the condition(s) this trial covers.